Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Authors

DOI:

https://doi.org/10.46570/utjms-2025-1397

Keywords:

MASLD, MASH, Pemafibrate, PPARS, Lipid profile, Liver fibrosis, Liver stiffness

Downloads

Published

2025-06-30

How to Cite

Hassan, M., Merza, N., Nawras, Y., Alfatlawi, H., al obaidi, hasan, Saab, O., Al Zubaidi, K., Al-sabbagh, D., mansur, S., Algodi, M., Al Najafi, O., Matbachi, R., Al Hamdany, T., Noori, Z., & Kobeissy, A. (2025). Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation: The University of Toledo Journal of Medical Sciences, 13(S3). https://doi.org/10.46570/utjms-2025-1397

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium

Most read articles by the same author(s)

1 2 > >>